Tag: CAR-T cell genomic safety

Home / CAR-T cell genomic safety

Categories

Risk of developing secondary tumors following CAR-T cell therapy is minimal – A Stanford Study

June 2024: The chances of getting secondary blood cancers after CAR-T cell therapy, a cell-based cancer treatment that got a lot of attention in 2017 for being effective against hard-to-treat blood ca...
car-t-cell-genomic-safety

Scan the code